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Abstract
Vaccinations and disease-screening services occupy an important position within the constellation 
of interventions designed to prevent, forestall or mitigate illness: they straddle the worlds of 
clinical medicine and public health. This paper focuses on a set of clinical preventive services that 
are recommended in the USA for adults aged 65 and older, based on their age and gender. These 
services include immunisations against influenza and pneumococcal disease, and screening for 
colorectal and breast cancers. We explore opportunities and challenges to enhance the delivery of 
these interventions, and describe some recently developed models for integrating prevention 
efforts based in clinician offices and in communities. We also report on a state-level surveillance 
measure that assesses whether older adults are ‘up to date’ on this subset of preventive services. 
To better protect the health of older Americans and change the projected trajectory of medical 
costs, expanded delivery of recommended vaccinations and disease screenings is likely to remain 
a focus for both US medicine and public health.
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Introduction
The number of older adults in the USA is increasing rapidly. In 1950, just over 10 million 
Americans were 65 years of age and older; in 2010, there were 35 million older adults and 
by 2030, there will be more than 70 million.1 The ageing of the population is accompanied 
by significant increases in chronic disease. By 2030, more than 81 million Americans are 
expected to have multiple chronic conditions.2 If left unchecked, the aggregate costs 
associated with treating these conditions will escalate sharply, from $1.3 trillion in 2003 to 
$4.2 trillion by 2023.3
Disease prevention has never been as important to the health of older Americans, and to the 
health of the US economy, as it is today. A recent economic analysis concludes that the rise 
of health care expenditures would be moderated by significantly broadening the provision of 
20 proven clinical preventive services, including screenings and vaccinations.4 Farley et al. 
estimate that 50,000–100,000 deaths per year among persons aged 80 or younger could be 
prevented through optimal use of nine clinical preventive services.5 However, current US 
spending on prevention accounts for only 2%–3% of health care expenditures;6 with the 
overwhelming portion of financial outlays covering hospital care, physician services, 
pharmaceutical treatments and administrative costs.7
This paper focuses on a set of clinical preventive services that are distinct in that they are 
recommended for adults aged 65 and older based on demographic characteristics (age and 
gender). We report on a state-level measure that tracks whether or not older adults are ‘up to 
date’ on this subset of clinical preventive services. With this foundation, the paper then 
explores opportunities and challenges to enhance the delivery and uptake of vaccinations 
and screenings for older adults, and describes some recently developed models for 
integrating the efforts of clinicians and communities. Combining the respective strengths of 
health care and public health is vital to assuring improved health for older Americans.8
Recommendations for routine vaccinations and screenings in the USA
Clinical preventive services occupy an important position within the constellation of 
interventions designed to prevent, forestall or mitigate illness: they straddle the worlds of 
clinical medicine and public health. In the USA, recommendations for clinicians regarding 
the delivery of clinical preventive services are issued by two independent groups of experts: 
the Advisory Committee on Immunization Practices (ACIP)9 and the US Preventive 
Services Task Force (USPSTF).10 These entities, convened by the Federal Government, are 
charged with rigorously evaluating the merits of preventive services, including 
immunisations (ACIP) and screening tests, counselling and chemoprophylaxis (USPSTF). 
The USPSTF presents its guidelines with an assigned grade. Services that receive grades ‘A’ 
or ‘B’ are fully recommended and deemed to provide a net benefit to recipients (Table 1). 
Grade ‘C’ indicates that the service should be provided only when there are compelling 
reasons, while a grade ‘D’ discourages a service from being used. A grade of ‘I’ indicates 
that there is insufficient evidence to assess the balance of the benefits and harms of the 
service properly. The Community Preventive Services Task Force (CPSTF), a national 
independent body of public health and prevention experts, makes recommendations about 
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public health interventions and policies designed to improve health and promote safety.11 
Between them, the USPSTF and the CPSTF evaluate evidence of how health can be 
improved by prevention in both clinical and community settings.
Recommended clinical preventive services are typically endorsed by leading US medical 
and public health organizations, although there are differences in expert opinion as to the 
optimal age range for the provision of some of them. The work of the ACIP and the 
USPSTF is updated periodically as research findings emerge. Recently, for example, breast 
cancer and prostate cancer screening recommendations have been revised.12 Although there 
are some differences in the guidelines for the delivery of cancer-screening services and adult 
vaccinations – and no clear consensus in the UK as to the effectiveness of routine breast 
cancer screening13 – public health recommendations in the USA, the UK14 and other 
European countries15 are broadly similar.
While the underuse of vaccinations and cancer screenings for older adults is a pressing 
concern, there is also evidence of the overuse of these services. For example, pneumococcal 
vaccination is sometimes repeated for patients who do not recall whether they have been 
previously immunised;16 indeed, ACIP recommendations state that the vaccine should be 
provided to patients whose immunisation status is uncertain.17 There is also evidence of the 
overuse of screening colonoscopy, mammography and Pap test among older Americans.18,19 
The USPSTF is cognisant of this problem and now explicitly recommends a minimum and 
maximum age for the routine use of each of these screenings.10 The USPSTF considers 
several areas of evidence in determining the appropriate age range for screening: whether 
the risk and potential burden of the targeted condition is absent or decreased in age-related 
subgroups; whether the potential burden of the condition is decreased by competing risks 
such as a shorter life expectancy; whether the accuracy of screening is modified by age; 
whether the risks of treatment of the condition differ by age; and whether negative results of 
prior screening tests significantly modify the risks of the condition in older adults.20
Public health surveillance for Vaccinations and screening
National and state tracking of clinical preventive services delivery is undertaken by a variety 
of surveillance initiatives. Public health surveillance refers to the ‘ongoing, systematic 
collection, analysis, and interpretation of health-related data essential to the planning, 
implementation, and evaluation of public health practice, closely integrated with the timely 
dissemination of these data to those responsible for prevention and control.’21 Beyond the 
traditional collection and analysis of vital records, state-level surveillance systems form the 
basis of a large network of surveillance systems in the USA. The Behavioral Risk Factor 
Surveillance System (BRFSS) is an essential mechanism for monitoring the uptake of 
clinical preventive services in states. The BRFSS collects monthly self-reported data in all 
50 states and four US territories on health risk behaviours, preventive health practices and 
health care access among community-dwelling adults. For many states, the BRFSS is the 
only available source of timely data on health-related behaviours, chronic disease and injury. 
More than 350,000 non-institutionalised adults aged 18 and older are interviewed each year, 
making the BRFSS the largest ongoing telephone health survey in the world.22
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The BRFSS has collected self-reported data on the receipt of adult immunisations and 
screenings for many years. Published national 2008 BRFSS data indicate that, among adults 
aged 65 and older, 70.9% reported receiving an influenza vaccination in the past year (as 
recommended by the ACIP), and 66.9% reported receiving the recommended one-time 
pneumococcal vaccination.23 In that same year, 72.8% of respondents aged 65 and older 
reported being screened for colorectal cancer (i.e. using a faecal occult blood test within one 
year or a lower endoscopy within ten years).24 Among women in the same age group, 78.5% 
reported receiving a mammogram within the past two years and 65.8% reported having a 
Pap test within the past three years. A recent report, Enhancing Use of Clinical Preventive 
Services among Older Adults, issued by four Health and Human Services agencies, provides 
data on a wide range of clinical preventive services, including those discussed here.25
In addition, The State of Aging and Health in America report has included an ‘up to date’ 
indicator for states focused on a subset of clinical preventive services available in the 
BRFSS that were recommended based on demographic characteristics (age and gender).26 
As such, these services are unlike other preventive services for older Americans – for 
example, abdominal aortic aneurism screening, which is recommended primarily for men 
aged 65–75 who have smoked, is contingent on a behavioural criterion.10 In 2010, Healthy 
People 2020, the ten-year national objectives for improving the health of all Americans, 
established an objective to increase by 10% the proportion of older adults aged 65 and older 
who are up-to-date on a subset of age- and gender-based preventive services.27 The indicator 
reports data separately for men (i.e. receipt of influenza and pneumococcal vaccinations and 
colorectal cancer screenings) and women (i.e. receipt of influenza and pneumococcal 
vaccinations and colorectal cancer and breast cancer screenings (all according to ACIP and 
USPSTF recommendations). Using 2008 BRFSS data, 46.3% of men aged 65 and older 
were up to date with core clinical preventive services, as were 47.9% of women. However, 
this measure does not include several USPSTF recommendations related to the prevention of 
critical prevention services related to smoking, cardiovascular events, obesity or alcohol 
misuse.
Ideally, the ‘up to date’ measure should include a full array of services recommended by the 
USPTF and the ACIP. The Agency for Healthcare Research and Quality (AHRQ) is 
providing leadership to the development of a set of measures on clinical preventive services 
for adults aged 50 years or over.28
Broadening the delivery of vaccinations and screenings: opportunities and 
challenges
Health care coverage for older adults is almost universal, due to the Medicare programme 
enacted in 1965.29 In 2008, Medicare covered nearly 45 million Americans30 – mainly 
adults ages 65 and older. Medicare’s commitment to providing preventive care to the 
nation’s older population was strengthened in 2010 by the Patient Protection and Affordable 
Care Act (Affordable Care Act or ACA),31 by eliminating cost-sharing requirements for 
certain clinical preventive services ranked ‘A’ or ‘B’ by the USPSTF. Moreover, ACA’s 
provision for a new annual wellness visit for Medicare beneficiaries includes a tailored 
assessment of prevention recommendations for individual enrollees.
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Although vaccinations are frequently delivered by health care organizations (visiting nurse 
agencies, pharmacies and for-profit companies) and local public health authorities, the 
provision of most preventive services falls primarily to work done in clinical settings. There 
have been ongoing efforts to introduce clinical system enhancements that dependably 
prompt patients and providers to adhere to preventive service recommendations. As early as 
1994, the US Public Health Services’ Office of Disease Prevention and Health Promotion 
launched the initiative Put Prevention into Practice to make practice guidelines and tools 
available to physicians to facilitate their delivery of preventive services in clinical settings.32
The expansion of electronic medical record databases and the increased linkages between 
patients, clinicians, health care systems and community-based services are at the core of 
efforts to improve the health information infrastructure. Such technology enhancements are 
critical to improving the quality, efficiency and patient-centredness of care,33 and health 
information exchanges are designed to improve the capability to electronically move clinical 
data among disparate systems while maintaining the confidentiality of the information being 
exchanged.34 Furthermore, health information organizations have been expanding their 
networks to include public health departments. Shapiro and colleagues describe potential 
applications to public health, wherein public health is directly responsible for providing 
health care for certain conditions as well as for tracking the delivery of clinical preventive 
services in neighbourhood settings, outside of the closed health care delivery system.35 The 
State Health Information Exchange Cooperative Agreement Program is currently providing 
funding for states to rapidly build capacity for exchanging health information at both the 
state and regional level.36
Another promising area is the development of personal health records that interface with the 
electronic health records used by health care systems.37 This type of technology is being 
used in health systems such as Partners Health Care in Massachusetts and offers the 
potential for consumers to record in their personal health record the screenings and 
vaccinations they have obtained outside of the system, and for this information to be 
transferred to their electronic health record. Barriers to the use of such technologies include 
the capital costs to develop these systems, inconsistencies across vendors limiting their 
interoperability, as well as data privacy concerns. In addition, access to such services may 
result in increased racial and ethnic disparities because such technology may not be equally 
available due to the economic differences between communities.38
Promoting clinical and community integration
To further acknowledge and reinforce the value of prevention, the ACA called for the 
development of the first-ever National Prevention and Health Promotion Strategy (National 
Prevention Strategy). One of the cornerstones of the National Prevention Strategy, issued in 
2011, is a focus on clinical and community preventive services with the goal to ‘ensure that 
prevention-focused health care and community prevention efforts are available, integrated, 
and mutually reinforcing. The provision of evidence-based clinical and community 
preventive services and the integration of these activities are central to improving and 
enhancing physical and mental health.’8
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As the National Prevention Strategy notes, some elements of improved integration of 
activities between medicine and public health can begin in the clinical setting. For example, 
if the clinician counsels a patient to stop smoking and prescribes an appropriate nicotine 
substitute, the patient might also be referred to a community ‘quit line’. Appropriate 
referrals can also be made to other community-based resources, such as chronic disease 
management programmes that focus on blood pressure, diabetes and cholesterol control.8,39
Another promising approach involves delivering amenable services in non-traditional 
settings. Special work sites, school sites and even polling places can provide convenient 
points of care for traditional populations that have yet to be reached.11,40–42 Additionally, 
community-based programmes can serve as conveners to ensure that people are linked by 
appointments to appropriate clinical settings for delivery of preventive services (e.g. 
mammography43 and colorectal cancer screening44). Voluntary health organizations, 
including the American Cancer Society and American Heart Association, have played 
important roles in overcoming barriers to increase uptake of preventive services. In the 
USA, more than 12,000 community members are working in schools, work sites, faith- and 
community-based organizations, clinics and hospitals to provide peer-to-peer support that 
increases access to health information, supports behaviour change, and improves access to 
care.45,46
Although most of these efforts are focused on the delivery of a single type of clinical 
preventive service, a recent review revealed several promising models for increasing the use 
of multiple preventive services.41 For example, Sickness Prevention Achieved through 
Regional Collaboration (SPARC) is a community-based collaborative model for delivering 
two or more preventive services as a ‘bundle’ in accessible community sites.47 The 
responsible ‘convening agency’ establishes strong partnerships between community 
organizations and clinical providers for vaccinations, screenings and follow-up care. 
Increases in the use of specific preventive services have been documented.42,48
As creative models continue to be tested, the need for detailed local data on their 
implementation and impact becomes critical. Considerable progress has been made to 
increase the accuracy of local information, for example through the BRFSS metropolitan 
and micropolitan statistical areas.49 However, policies and new technologies are needed to 
help improve timely access to administrative and records data, along with advancement in 
the ways in which data are collected, managed, accessed and shared.
Conclusion
Improving the delivery of vaccinations and screenings to older Americans remains an 
important US public health and policy challenge. This goal is one element in a 
comprehensive set of national strategies to effectively and systematically reduce the impact 
of disease on a rapidly ageing population. Although clinical preventive services are covered 
by Medicare – and there is a broad consensus among health professions that they are of 
benefit – no more than half of the adult population aged 65 and older receives the full 
protection conferred by a core set of services. Successfully tackling this challenge will 
require more innovation, more translation of promising research into public health practice, 
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better health promotion, and fuller deployment of model programmes that can create 
‘prevention zones’ in which clinical and community services are accessible and fully 
integrated. Such efforts will be particularly important in underserved communities. For the 
US health system to truly protect the health of older Americans and change the projected 
trajectory of medical costs, expanded delivery of recommended vaccinations and disease 
screenings must remain a focus for both medicine and public health.
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Table 1
Clinical preventive services for adults age 50 and older, recommended based on age and gender*
Preventive service Recommendation
Influenza vaccine† All persons six months and older should receive one dose annually.
Pneumococcal vaccine† All persons age 65 and older should receive one dose of the pneumococcal vaccine, including 
previously unvaccinated persons and persons who have not received vaccine within five years (and 
were less than 65 years of age at the time of vaccination). All persons in this age category who have 
unknown vaccination status should receive one dose of vaccine.
Tetanus-diphtheria booster All adults should receive one dose every 10 years.
Varicella vaccine All adults without evidence of immunity (documentation of previous immunization or a history of 
varicella/chickenpox) should receive two doses.
Zoster vaccine All adults age 60 and older should receive one dose.
Alcohol misuse screening and 
counselling
All adults age 50 and older.
Aspirin prophylaxis Men aged 45–79 and women aged 55–79, when the benefit of aspirin prophylaxis is likely to exceed 
the risk.
Blood pressure screening All adults age 18 and older should have their blood pressure checked. A recommended screening 
interval is every two years in persons with blood pressure less than 120/80 mm Hg; every year with 
systolic blood pressure of 120–139 mm Hg or diastolic blood pressure of 80–89 mm Hg.
Breast cancer screening† All women, beginning at age 50 and continuing until age 74, should have a mammogram every two 
years.
Cervical cancer screening† All women who have been sexually active should receive screening, if they have a cervix. Women 
older than age 65 do not need routine screening if they have had recent screenings with normal results 
and are not otherwise at high risk for cervical cancer.
Cholesterol screening All men age 35 and older should be screened. A recommended screening interval is every five years, 
but shorter for adults who have lipid levels close to patients warranting therapy, and longer for adults 
who have had repeatedly normal lipid levels.
Colorectal cancer screening† All adults, beginning at age 50 years and continuing until age 75, should receive screening for 
colorectal cancer using faecal occult blood testing, sigmoidoscopy or colonoscopy. Evidence suggests 
a maximal benefit from screening every 10 years.
Depression screening All adults age 18 and older when staff-assisted support is in place.
Obesity screening and counselling All adults.
Osteoporosis screening All women age 65 years or older and in younger women whose fracture risk is equal to or greater than 
that of a 65-year-old white woman who has no additional risk factors.
Tobacco screening and counselling All adults
*
Each of these clinical preventive services is rated at the ‘A’ (highly recommended) or ‘B’ (recommended) level by the US Preventive Services 
Task Force (USPSTF) or by the Advisory Committee on Immunization Practices (ACIP).
†
Included in the Healthy People 2020 national health objectives ‘up to date’ measure for older adults.
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